Skip to main content
Article thumbnail
Location of Repository

Macrophage-Specific ApoE Gene Repair Reduces Diet-Induced Hyperlipidemia and Atherosclerosis in Hypomorphic Apoe Mice

By Nathalie Gaudreault, Nikit Kumar, Victor R. Olivas, Delphine Eberlé, Joseph H. Rapp and Robert L. Raffai
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3351426
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1993). Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions.
    2. (1978). Alterations in tissue lipids of rats subjected to wholebody X-irradiation.
    3. (1988). Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.
    4. (2002). Atherosclerosis in C3H/HeJ mice reconstituted with apolipoprotein E-null bone marrow.
    5. (2004). Bore ´n J
    6. (1989). Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis.
    7. (1998). Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins.
    8. (1999). Determination of the lower threshold of apolipoprotein E resulting in remnant lipoprotein clearance.
    9. (2008). Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.
    10. (2001). Effect of gammairradiation and bone marrow transplantation on atherosclerosis
    11. (2004). Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    12. (1999). Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice.
    13. (1994). Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3.
    14. (1999). Fo ¨rster I
    15. (1996). Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?
    16. (2003). Hepatocyte-derived ApoE is more effective than non-hepatocyte-derived ApoE in remnant lipoprotein clearance.
    17. (2002). Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism.
    18. (1986). Immunoreactive apolipoprotein E is a widely distributed cellular protein. Immunohistochemical localization of apolipoprotein E in baboon tissues.
    19. (1997). Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages.
    20. (1983). Independent pathways for secretion of cholesterol and apolipoprotein E by macrophages.
    21. (1995). Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall.
    22. (2001). Introduction of human apolipoprotein E4 ‘‘domain interaction’’ into mouse apolipoprotein E.
    23. (2008). Intron-3 retention/splicing controls neuronal expression of apolipoprotein E in the CNS.
    24. (1997). Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoEdeficient mice.
    25. (1998). Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma.
    26. (1995). Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.
    27. (1991). Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.
    28. (1995). Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation.
    29. (1985). Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80.
    30. (2000). Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E.
    31. (1999). Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery wall reduces early foam cell lesion formation.
    32. (1993). Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein Eenriched remnant lipoproteins by cultured cells.
    33. (1992). Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.
    34. (1992). Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.
    35. (1995). Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.